Achieve Life Sciences Inc (ACHV)
5.305
-0.04
(-0.66%)
USD |
NASDAQ |
May 30, 16:00
5.305
0.00 (0.00%)
After-Hours: 17:51
Achieve Life Sciences Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.006M |
| September 30, 2023 | -0.015M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.003M |
| June 30, 2020 | -0.012M |
| March 31, 2020 | -0.002M |
| December 31, 2019 | -0.001M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 2.347M |
| March 31, 2019 | 2.69M |
| December 31, 2018 | -3.709M |
| September 30, 2018 | -1.39M |
| June 30, 2018 | -0.036M |
| March 31, 2018 | 0.01M |
| December 31, 2017 | 0.272M |
| Date | Value |
|---|---|
| September 30, 2017 | 12.38M |
| June 30, 2017 | |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.194M |
| September 30, 2016 | 8.482M |
| June 30, 2016 | -1.978M |
| March 31, 2016 | -6.31M |
| December 31, 2015 | 2.504M |
| September 30, 2015 | -11.31M |
| June 30, 2015 | 2.848M |
| March 31, 2015 | 3.877M |
| December 31, 2014 | -14.12M |
| September 30, 2014 | -5.076M |
| June 30, 2014 | 8.863M |
| March 31, 2014 | 15.70M |
| December 31, 2013 | 9.179M |
| September 30, 2013 | 4.407M |
| June 30, 2013 | 7.603M |
| March 31, 2013 | 11.24M |
| December 31, 2012 | 16.23M |
| September 30, 2012 | 10.07M |
| June 30, 2012 | -29.43M |
| March 31, 2012 | -18.06M |
| December 31, 2011 | 17.21M |
| September 30, 2011 | 0.886M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.015M
Minimum
Sep 2023
2.347M
Maximum
Jun 2019
0.2098M
Average
-0.001M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Accelerate Diagnostics Inc | -0.513M |
| Atossa Therapeutics Inc | -0.006M |
| ENDRA Life Sciences Inc | -0.0238M |
| Perspective Therapeutics Inc | -47.30M |
| Electromed Inc | -0.129M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.288M |
| Cash from Financing (Quarterly) | 56.11M |
| Free Cash Flow | -21.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2111 |
| Free Cash Flow Yield | -18.73% |